$Elective pelvic nodal irradiation in elderly men treated with hypofractionated radiotherapy$

Elective pelvic nodal irradiation in elderly men treated with hypofractionated radiotherapy

Saved in:

Bibliographic Details
Main Authors:	Rachel M. Glicksman, Andrew Loblaw, Patrick Cheung
Format:	Article
Language:	English
Published:	Elsevier 2025-01-01
Series:	Clinical and Translational Radiation Oncology
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405630824001654
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Hypofractionated Prostate Radiotherapy with or without Conventionally Fractionated Nodal Irradiation: Clinical Toxicity Observations and Retrospective Daily Dosimetry
by: Andrew M. McDonald, et al.
Published: (2012-01-01)

Elective pelvic nodal irradiation for elderly patients with high-risk prostate cancer: A more patient-oriented approach
by: Federico Iori, et al.
Published: (2025-03-01)

Phase II single vs hypofractionated irradiation for timely access to partial breast radiotherapy (SHIFT-PB)
by: Robert Olson, et al.
Published: (2025-08-01)

Hypofractionated radiotherapy for newly diagnosed elderly glioblastoma patients: A systematic review and network meta-analysis.
by: Suely Maymone de Melo, et al.
Published: (2021-01-01)

Evaluating the Effects of Prostate Radiotherapy Intensified with Pelvic Nodal Radiotherapy and Androgen Deprivation Therapy on Myelosuppression: Single-Institution Experience
by: Yousef Katib, et al.
Published: (2024-09-01)

Acute toxicity outcomes in Egyptian early-stage breast cancer: ultra-hypofractionated versus hypofractionated radiotherapy
by: Ahmed Magdy, et al.
Published: (2025-05-01)

Investigation of Ki-67 and Clinical Outcome in Feline Nasal Adenocarcinoma Treated Using Hypofractionated Radiotherapy
by: Premkamon Aonta, et al.
Published: (2024-12-01)

Carcinoma buccal mucosa treated with definitive hypofractionated accelerated radiotherapy: a retrospective analysis of treatment outcomes
by: Geethu Babu, et al.
Published: (2025-07-01)

Hypofractionated Palliative Radiotherapy for Relapsed and Refractory High-Risk Neuroblastoma
by: Ellery Koelker-Wolfe, et al.
Published: (2025-02-01)

Comments on: Carcinoma buccal mucosa treated with definitive hypofractionated accelerated radiotherapy: a retrospective analysis of treatment outcomes
by: Efsun Somay, et al.
Published: (2025-07-01)

Efficacy Analysis of Hypofractionated Radiotherapy for Oligometastatic Tumors: A Retrospective Study
by: Qian Sun MD, et al.
Published: (2025-01-01)

Response to comments on: Carcinoma buccal mucosa treated with definitive hypofractionated accelerated radiotherapy: a retrospective analysis of treatment outcomes
by: Geethu Babu, et al.
Published: (2025-07-01)

Real-world insights into moderately hypofractionated thoracic radiotherapy in elderly and multimorbid patients with stage II/III NSCLC: a retrospective study
by: Helene Kravutske, et al.
Published: (2025-07-01)

Choroidal Melanoma Treated with Linear Accelerator-based Hypofractionated Stereotactic Radiotherapy: First Case of Globe Conservation in Uveal Melanoma from the Philippines
by: Raymund V. Tanchuling, MD, et al.
Published: (2025-06-01)

Hypofractionated Proton Boost Combined with External Beam Radiotherapy for Treatment of Localized Prostate Cancer
by: Silvia Johansson, et al.
Published: (2012-01-01)

Tumor volume changes after stereotactic, hypofractionated and conventional radiotherapy in paragangliomas of head and neck
by: Paweł J. Polanowski, et al.
Published: (2024-09-01)

Could elective nodal irradiation for locally advanced rectal cancer be omitted in the context of total neoadjuvant therapy? An analysis of the recurrence sites of rectal cancer
by: Linlin Xiao, et al.
Published: (2024-11-01)

Hypofractionated versus conventional radiotherapy for head-and-neck cancer: A systematic review and meta-analysis
by: Arnab Roy, et al.
Published: (2025-01-01)

Analysis of safety of postoperative accelerated hypofractionated radiotherapy for patients with stage I-IIIA breast cancer
by: G. V. Afonin, et al.
Published: (2020-04-01)

Hypofractionated radiotherapy regimens after organ-sparing surgery for stages I–IIa breast cancer
by: Yu. V. Efimkina, et al.
Published: (2014-08-01)

Clinical outcomes and prognostic factors of repeated conventional hypofractionated radiotherapy for recurrent intranasal tumors in dogs
by: Hirona Ueno, et al.
Published: (2025-02-01)

Radiation-induced unilateral diaphragmatic paralysis following breast and nodal radiotherapy
by: Sathish Kumar Krishnan, et al.
Published: (2025-06-01)

Examining the role of elective pelvic radiotherapy in patients Diagnosed with high- and very High-Risk Non-Metastatic prostate cancer
by: István Nahaji, et al.
Published: (2025-07-01)

A Prospective Study to Assess Response and Toxicity of Hypofractionated Palliative Radiotherapy in Advanced Inoperable Oropharyngeal Carcinoma
by: Ayush Naik, et al.
Published: (2025-07-01)

Implementation of ultra-hypofractionated radiotherapy for breast cancer in the Netherlands in 2020–2023, using registry data and questionnaires
by: Anouk H. Eijkelboom, et al.
Published: (2025-06-01)

Use of hypofractionated radiotherapy regimens after organ-sparing surgery for Stages I–IIA breast cancers
by: Yu. V. Efimkina, et al.
Published: (2014-08-01)

Hypofractionated radiotherapy (RT) combined with dihydroartemisinin (DHA): No synergistic effect observed in a preliminary animal study
by: Yuenan Wang, et al.
Published: (2025-03-01)

Hypofractionated Postmastectomy Radiotherapy (HF-PMRT): What did We Learn from COVID-19 Era?
by: Viola Salvestrini, et al.
Published: (2023-02-01)

Tattoo-less chest wall and regional nodal irradiation using surface imaging
by: Boris Mueller, et al.
Published: (2025-06-01)

Study protocol of Elective Para-aortic and pelvic versus Pelvic only Irradiation in pelvic node positive Cervical cancer: a multicentric open labelled phase III randomised controlled trial (EPIC Study)
by: Sudeep Gupta, et al.
Published: (2024-11-01)

Normal tissue complication probability modeling for late rectal bleeding after conventional or hypofractionated radiotherapy for prostate cancer
by: Christian A.M. Jongen, et al.
Published: (2025-01-01)

Local control and possibility of tailored salvage after hypofractionated stereotactic radiotherapy of the cavity after brain metastases resection
by: Angelika Bilger, et al.
Published: (2018-06-01)

An accelerated hypofractionated radiotherapy regimen in patients after organ-sparing surgery for stages I–IIA breast cancer
by: I. A. Gladilina, et al.
Published: (2016-11-01)

Early Dynamics of Circulating Tumor DNA Following Curative Hypofractionated Radiotherapy Related to Disease Control in Lung Cancer
by: Kyungmi Yang, et al.
Published: (2025-05-01)

Hypofractionated stereotactic radiotherapy using coplanar VMAT for single small brain metastasis: dosimetric analysis and clinical outcomes
by: Jialu Lai, et al.
Published: (2025-02-01)

Verteporfin‐Mediated In Situ Nanovaccine Based on Local Conventional‐Dose Hypofractionated Radiotherapy Enhances Antitumor and Immunomodulatory Effect
by: Zhifan Zhang, et al.
Published: (2025-05-01)

Case Report: Proximal bronchial injury in small-cell lung cancer patient after moderately hypofractionated radiotherapy
by: Tongsong Zhang, et al.
Published: (2025-05-01)

Hypofractionated adjuvant radiotherapy in cutaneous squamous cell and basal cell carcinoma of the head and neck: 50(Gy) in 20 study
by: Marcus Hu, et al.
Published: (2025-03-01)

Efficacy and Safety of Hypofractionated Radiotherapy With a Simultaneous Integrated Boost and With a Sequential Boost After Breast‐Conserving Surgery
by: Na Li, et al.
Published: (2025-03-01)

Feasibility of elective neck irradiation in treating node-negative nasopharyngeal carcinoma patients: a meta-analysis
by: Jianfeng Zhou, et al.
Published: (2025-05-01)